The role of transrectal ultrasonography on the palpable and impalpable abnormal prostate

T. S. Tzai, J. S.N. Lin, I. C. Yeh, N. H. Chow

研究成果: Article

7 引文 (Scopus)

摘要

Two hundred and three male patients underwent transrectal ultrasonography (TRUS) examination because of palpable nodule or hard consistency of the prostate. Of these, 56 of 65 (86.2%) digital rectal examination (DRE)-abnormal and 34 of 138 (24.6%) DRE-normal patients received transrectal sono-guided core needle biopsy. Among the DRE-abnormal patients, 18 (32.1%) had prostatic adenocarcinoma by biopsy with 2 additional patients who had initial negative biopsies eventually found to have cancer by transurethral resection of the prostate. In contrast, only 2 (5.9%) of 34 DRE-normal patients had cancers that were both hypoechoic and peripheral zone located. In 13 patients with transitional zone located lesions (hypacchoic 9, isoechoic 4), none had cancer, Of 27 patients who had normal DRE and unsuspected TRUS and received transurethral prostatectomy because of bladder outlet obstruction, 4 (14.8%) had cancer. In this study, hypoechoic lesions were found in 68 patients, among them 60 (88.2%) underwent biopsy but only 14 (23.3%) had cancer. From the results of this study, we concluded that TRUS can be a useful adjunct of DRE in detecting prostatic malignancy, especially when there has been an abnormal DRE, but its role on a digitally normal prostate requires further evaluation, Serum prostate-specific antigen can be an additional indicator to increase the prostate cancer detection rate.

原文English
頁(從 - 到)142-145
頁數4
期刊European Urology
27
發行號2
出版狀態Published - 1995 一月 1

指紋

Digital Rectal Examination
Prostate
Ultrasonography
Neoplasms
Transurethral Resection of Prostate
Biopsy
Large-Core Needle Biopsy
Urinary Bladder Neck Obstruction
Prostate-Specific Antigen
Prostatic Neoplasms
Adenocarcinoma
Serum

All Science Journal Classification (ASJC) codes

  • Urology

引用此文

Tzai, T. S. ; Lin, J. S.N. ; Yeh, I. C. ; Chow, N. H. / The role of transrectal ultrasonography on the palpable and impalpable abnormal prostate. 於: European Urology. 1995 ; 卷 27, 編號 2. 頁 142-145.
@article{7bc830b0207b43f1ae3ec038c606b4ad,
title = "The role of transrectal ultrasonography on the palpable and impalpable abnormal prostate",
abstract = "Two hundred and three male patients underwent transrectal ultrasonography (TRUS) examination because of palpable nodule or hard consistency of the prostate. Of these, 56 of 65 (86.2{\%}) digital rectal examination (DRE)-abnormal and 34 of 138 (24.6{\%}) DRE-normal patients received transrectal sono-guided core needle biopsy. Among the DRE-abnormal patients, 18 (32.1{\%}) had prostatic adenocarcinoma by biopsy with 2 additional patients who had initial negative biopsies eventually found to have cancer by transurethral resection of the prostate. In contrast, only 2 (5.9{\%}) of 34 DRE-normal patients had cancers that were both hypoechoic and peripheral zone located. In 13 patients with transitional zone located lesions (hypacchoic 9, isoechoic 4), none had cancer, Of 27 patients who had normal DRE and unsuspected TRUS and received transurethral prostatectomy because of bladder outlet obstruction, 4 (14.8{\%}) had cancer. In this study, hypoechoic lesions were found in 68 patients, among them 60 (88.2{\%}) underwent biopsy but only 14 (23.3{\%}) had cancer. From the results of this study, we concluded that TRUS can be a useful adjunct of DRE in detecting prostatic malignancy, especially when there has been an abnormal DRE, but its role on a digitally normal prostate requires further evaluation, Serum prostate-specific antigen can be an additional indicator to increase the prostate cancer detection rate.",
author = "Tzai, {T. S.} and Lin, {J. S.N.} and Yeh, {I. C.} and Chow, {N. H.}",
year = "1995",
month = "1",
day = "1",
language = "English",
volume = "27",
pages = "142--145",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "2",

}

The role of transrectal ultrasonography on the palpable and impalpable abnormal prostate. / Tzai, T. S.; Lin, J. S.N.; Yeh, I. C.; Chow, N. H.

於: European Urology, 卷 27, 編號 2, 01.01.1995, p. 142-145.

研究成果: Article

TY - JOUR

T1 - The role of transrectal ultrasonography on the palpable and impalpable abnormal prostate

AU - Tzai, T. S.

AU - Lin, J. S.N.

AU - Yeh, I. C.

AU - Chow, N. H.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Two hundred and three male patients underwent transrectal ultrasonography (TRUS) examination because of palpable nodule or hard consistency of the prostate. Of these, 56 of 65 (86.2%) digital rectal examination (DRE)-abnormal and 34 of 138 (24.6%) DRE-normal patients received transrectal sono-guided core needle biopsy. Among the DRE-abnormal patients, 18 (32.1%) had prostatic adenocarcinoma by biopsy with 2 additional patients who had initial negative biopsies eventually found to have cancer by transurethral resection of the prostate. In contrast, only 2 (5.9%) of 34 DRE-normal patients had cancers that were both hypoechoic and peripheral zone located. In 13 patients with transitional zone located lesions (hypacchoic 9, isoechoic 4), none had cancer, Of 27 patients who had normal DRE and unsuspected TRUS and received transurethral prostatectomy because of bladder outlet obstruction, 4 (14.8%) had cancer. In this study, hypoechoic lesions were found in 68 patients, among them 60 (88.2%) underwent biopsy but only 14 (23.3%) had cancer. From the results of this study, we concluded that TRUS can be a useful adjunct of DRE in detecting prostatic malignancy, especially when there has been an abnormal DRE, but its role on a digitally normal prostate requires further evaluation, Serum prostate-specific antigen can be an additional indicator to increase the prostate cancer detection rate.

AB - Two hundred and three male patients underwent transrectal ultrasonography (TRUS) examination because of palpable nodule or hard consistency of the prostate. Of these, 56 of 65 (86.2%) digital rectal examination (DRE)-abnormal and 34 of 138 (24.6%) DRE-normal patients received transrectal sono-guided core needle biopsy. Among the DRE-abnormal patients, 18 (32.1%) had prostatic adenocarcinoma by biopsy with 2 additional patients who had initial negative biopsies eventually found to have cancer by transurethral resection of the prostate. In contrast, only 2 (5.9%) of 34 DRE-normal patients had cancers that were both hypoechoic and peripheral zone located. In 13 patients with transitional zone located lesions (hypacchoic 9, isoechoic 4), none had cancer, Of 27 patients who had normal DRE and unsuspected TRUS and received transurethral prostatectomy because of bladder outlet obstruction, 4 (14.8%) had cancer. In this study, hypoechoic lesions were found in 68 patients, among them 60 (88.2%) underwent biopsy but only 14 (23.3%) had cancer. From the results of this study, we concluded that TRUS can be a useful adjunct of DRE in detecting prostatic malignancy, especially when there has been an abnormal DRE, but its role on a digitally normal prostate requires further evaluation, Serum prostate-specific antigen can be an additional indicator to increase the prostate cancer detection rate.

UR - http://www.scopus.com/inward/record.url?scp=0028947821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028947821&partnerID=8YFLogxK

M3 - Article

C2 - 7538084

AN - SCOPUS:0028947821

VL - 27

SP - 142

EP - 145

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 2

ER -